This inventor holds 2 USPTO granted patents. Top assignee: Injet Digital Aerosols Limited. Active years: 2006-2012.
Company Filing History:
Years Active: 2006-2012
Title: The Innovative Contributions of Jeffrey P. Taub
Introduction
Jeffrey P. Taub is a notable inventor based in Escondido, California. He has made significant contributions to the field of respiratory delivery systems, with a focus on inhalation devices. His work has led to the development of innovative technologies that enhance the delivery of therapeutic compounds.
Latest Patents
Jeffrey P. Taub holds 2 patents that showcase his expertise in inhalation technology. His latest patents include an "Inhalation device having an optimized air flow path," which is designed for the pulmonary delivery of a compound. This device features a reservoir for storing a compound, a system for generating particles of a desired size, and a housing that provides a substantially unobstructed airflow path between the inlet and outlet. Another significant invention is the "Inhaler with airflow regulation," which is a respiratory delivery system that discharges substances for inhalation. This inhaler includes multiple airflow inlets and outlets, an airflow passage, and an ejection actuator, along with an airflow regulation assembly that adjusts the passage size to maintain a specific flow rate.
Career Highlights
Jeffrey P. Taub is associated with Injet Digital Aerosols Limited, where he continues to innovate in the field of aerosol delivery systems. His work has been instrumental in advancing the technology used in inhalers and other respiratory devices.
Collaborations
Throughout his career, Jeffrey has collaborated with notable professionals in the field, including Olaf Reinhold and Robert P. Lackey. These collaborations have contributed to the development of cutting-edge technologies in respiratory delivery systems.
Conclusion
Jeffrey P. Taub's contributions to inhalation technology have made a significant impact on the field of respiratory delivery systems. His innovative patents and collaborations highlight his dedication to improving therapeutic delivery methods.